Medivir substance shows effect on multi resistant HIV
Medivir substance shows effect on multi resistant HIV Dr Thomas Merigan at Stanford University today presents new data where one of Medivir's patented substances, alovudine (FLT) is shown to inhibit multi resistant HIV in laboratory tests. This presentation is being given at an international congress on HIV treatment in Rome. "Multi resistant HIV is today a growing problem. The combination treatments given with current HIV drugs have prolonged life for HIV patients. Unfortunately multi resistance develops and existing drugs can not keep the virus in check. Patients with these multi